142 related articles for article (PubMed ID: 9479568)
41. Maximum-likelihood analysis of human T-cell X chromosome inactivation patterns: normal women versus carriers of X-linked severe combined immunodeficiency.
Puck JM; Stewart CC; Nussbaum RL
Am J Hum Genet; 1992 Apr; 50(4):742-8. PubMed ID: 1550118
[TBL] [Abstract][Full Text] [Related]
42. Gene therapy for XSCID: the first success of gene therapy.
Kohn DB
Pediatr Res; 2000 Nov; 48(5):578. PubMed ID: 11044472
[No Abstract] [Full Text] [Related]
43. Missense mutation in exon 7 of the common gamma chain gene causes a moderate form of X-linked combined immunodeficiency.
Schmalstieg FC; Leonard WJ; Noguchi M; Berg M; Rudloff HE; Denney RM; Dave SK; Brooks EG; Goldman AS
J Clin Invest; 1995 Mar; 95(3):1169-73. PubMed ID: 7883965
[TBL] [Abstract][Full Text] [Related]
44. Molecular and genetic basis of X-linked immunodeficiency disorders.
Puck JM
J Clin Immunol; 1994 Mar; 14(2):81-9. PubMed ID: 8195317
[TBL] [Abstract][Full Text] [Related]
45. Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency.
Puel A; Ziegler SF; Buckley RH; Leonard WJ
Nat Genet; 1998 Dec; 20(4):394-7. PubMed ID: 9843216
[TBL] [Abstract][Full Text] [Related]
46. Efficient detection of thirty-seven new IL2RG mutations in human X-linked severe combined immunodeficiency.
Niemela JE; Puck JM; Fischer RE; Fleisher TA; Hsu AP
Clin Immunol; 2000 Apr; 95(1 Pt 1):33-8. PubMed ID: 10794430
[TBL] [Abstract][Full Text] [Related]
47. The structure and function of gamma c-dependent cytokines and receptors: regulation of T lymphocyte development and homeostasis.
He YW; Malek TR
Crit Rev Immunol; 1998; 18(6):503-24. PubMed ID: 9862091
[TBL] [Abstract][Full Text] [Related]
48. A critical role for IL-21 in regulating immunoglobulin production.
Ozaki K; Spolski R; Feng CG; Qi CF; Cheng J; Sher A; Morse HC; Liu C; Schwartzberg PL; Leonard WJ
Science; 2002 Nov; 298(5598):1630-4. PubMed ID: 12446913
[TBL] [Abstract][Full Text] [Related]
49. Comparative mapping of canine and human proximal Xq and genetic analysis of canine X-linked severe combined immunodeficiency.
Deschênes SM; Puck JM; Dutra AS; Somberg RL; Felsburg PJ; Henthorn PS
Genomics; 1994 Sep; 23(1):62-8. PubMed ID: 7829103
[TBL] [Abstract][Full Text] [Related]
50. [Molecular genetics of X-linked primary immunodeficiencies: advances in diagnosis and prevention].
Carbonara A; Brusco A; Carbonara C
Ann Ital Med Int; 1996; 11(3):180-6. PubMed ID: 8998263
[TBL] [Abstract][Full Text] [Related]
51. Unique risk factors for insertional mutagenesis in a mouse model of XSCID gene therapy.
Shou Y; Ma Z; Lu T; Sorrentino BP
Proc Natl Acad Sci U S A; 2006 Aug; 103(31):11730-5. PubMed ID: 16864781
[TBL] [Abstract][Full Text] [Related]
52. Selective growth advantage of wild-type lymphocytes in X-linked SCID recipients.
Kume A; Koremoto M; Mizukami H; Okada T; Hanazono Y; Sugamura K; Ozawa K
Bone Marrow Transplant; 2002 Jul; 30(2):113-8. PubMed ID: 12132050
[TBL] [Abstract][Full Text] [Related]
53. A novel immunodeficient mouse model--RAG2 x common cytokine receptor gamma chain double mutants--requiring exogenous cytokine administration for human hematopoietic stem cell engraftment.
Mazurier F; Fontanellas A; Salesse S; Taine L; Landriau S; Moreau-Gaudry F; Reiffers J; Peault B; Di Santo JP; de Verneuil H
J Interferon Cytokine Res; 1999 May; 19(5):533-41. PubMed ID: 10386866
[TBL] [Abstract][Full Text] [Related]
54. The defective gene in X-linked severe combined immunodeficiency encodes a shared interleukin receptor subunit: implications for cytokine pleiotropy and redundancy.
Leonard WJ
Curr Opin Immunol; 1994 Aug; 6(4):631-5. PubMed ID: 7946053
[TBL] [Abstract][Full Text] [Related]
55. Patterns of X chromosome inactivation in haematopoietic cells of female carriers of X linked severe combined immunodeficiency.
Hendriks RW; Kraakman ME; Schuurman RK
Immunodeficiency; 1993; 4(1-4):263-5. PubMed ID: 8167715
[TBL] [Abstract][Full Text] [Related]
56. T cell reconstitution by haploidentical BMT does not restore the diversification of the Ig heavy chain gene in patients with X-linked SCID.
Minegishi Y; Ishii N; Tsuchida M; Okawa H; Sugamura K; Yata J
Bone Marrow Transplant; 1995 Dec; 16(6):801-6. PubMed ID: 8750273
[TBL] [Abstract][Full Text] [Related]
57. Impairment of ligand binding and growth signaling of mutant IL-2 receptor gamma-chains in patients with X-linked severe combined immunodeficiency.
Ishii N; Asao H; Kimura Y; Takeshita T; Nakamura M; Tsuchiya S; Konno T; Maeda M; Uchiyama T; Sugamura K
J Immunol; 1994 Aug; 153(3):1310-7. PubMed ID: 8027558
[TBL] [Abstract][Full Text] [Related]
58. X-linked severe combined immunodeficiency in a family of Cardigan Welsh corgis.
Pullen RP; Somberg RL; Felsburg PJ; Henthorn PS
J Am Anim Hosp Assoc; 1997; 33(6):494-9. PubMed ID: 9358416
[TBL] [Abstract][Full Text] [Related]
59. Nonrandom X chromosome inactivation in natural killer cells from obligate carriers of X-linked severe combined immunodeficiency.
Wengler GS; Allen RC; Parolini O; Smith H; Conley ME
J Immunol; 1993 Jan; 150(2):700-4. PubMed ID: 8093460
[TBL] [Abstract][Full Text] [Related]
60. Sib understanding of genetics and attitudes toward carrier testing for X-linked severe combined immunodeficiency.
Fanos JH; Davis J; Puck JM
Am J Med Genet; 2001 Jan; 98(1):46-56. PubMed ID: 11426455
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
